The top 10 highest paid biopharma R&D executives in 2019
FierceBiotech has compiled a list of the top 10 highest paid biopharma R&D executives in 2019. Although one might think that the companies with the biggest R&D budgets would match those paying their chief scientists the most, that theory doesn’t exactly hold up. See who made the list below:
- George Yancopoulos, Regeneron
- Paul Stoffels, Johnson & Johnson
- Mikael Dolsten, Pfizer
- Michael Severino, AbbVie
- Roger Perlmutter, Merck & Co.
- Thomas Lynch, Bristol Myers Squibb
- Reshma Kewalramani, Vertex
- Roger Dansey, Seattle Genetics
- Daniel Skovronsky, Eli Lilly
- David Reese, Amgen
